Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 679 Carcinoma, Non-Small-Cell Lung 324 Neoplasms 168 Breast Neoplasms 163 Urinary Bladder Neoplasms 157 Lung Neoplasms 157 Neoplasm Metastasis 139 Cholangiocarcinoma 112 Ovarian Neoplasms 106 Biliary Tract Neoplasms 92 Lymphoma, Large B-Cell, Diffuse 73 Nasopharyngeal Carcinoma 70 Lymphoma 66 Sarcoma 63 Recurrence 62 Gallbladder Neoplasms 60 Carcinoma, Transitional Cell 55 Triple Negative Breast Neoplasms 54 Hodgkin Disease 52 Colorectal Neoplasms 49 Fallopian Tube Neoplasms 48 Lymphoma, Non-Hodgkin 47 Adenocarcinoma 45 Bile Duct Neoplasms 40 Carcinoma, Ovarian Epithelial 31 Non-Muscle Invasive Bladder Neoplasms 30 Uterine Cervical Neoplasms 28 Carcinoma 28 Unspecified Adult Solid Tumor, Protocol Specific 27 Adenocarcinoma of Lung 27

Interventions

Ipilimumab 29 Nivolumab 23 pembrolizumab 14 incomplete Freund's adjuvant 10 Cyclophosphamide 10 Interleukin-2 9 Melphalan 8 CTLA-4 Antigen 8 sargramostim 7 Temozolomide 7 MART-1 Antigen 7 Dacarbazine 7 tebentafusp 6 Ranibizumab 6 montanide ISA 51 5 fludarabine phosphate 5 fludarabine 5 Sunitinib 5 Radiosurgery 5 Carboplatin 5 Bevacizumab 5 aldesleukin 4 aflibercept 4 Magnetic Resonance Spectroscopy 4 Granulocyte-Macrophage Colony-Stimulating Factor 4 Blood Specimen Collection 4 Biopsy 4 trametinib 3 sotrastaurin 3 relatlimab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Uveal Melanoma × Gemcitabine × Clear all

NCT00168870 2007-08-31

Study of Metastatic Ocular Melanoma

Charite University, Berlin, Germany

Phase 2 Unknown

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡